Solak M - Search Results

1

The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.

Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K. Turkoz FP, et al. Among authors: solak m. J BUON. 2013 Apr-Jun;18(2):335-41. J BUON. 2013. PMID: 23818343 Free article.

2

Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey.

Turkoz FP, Solak M, Aksoy S, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Simsek E, Ozisik Y, Altundag K. Turkoz FP, et al. Among authors: solak m. J BUON. 2012 Oct-Dec;17(4):649-57. J BUON. 2012. PMID: 23335520

3

Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients.

Kertmen N, Sahin U, Keskin O, Solak M, Petekkaya I, Babacan T, Sarici F, Arik Z, Kizilarslanoglu B, Altundag K. Kertmen N, et al. Among authors: solak m. J BUON. 2012 Oct-Dec;17(4):797. J BUON. 2012. PMID: 23335545 No abstract available.

4

Impact of the obesity on lymph node status in operable breast cancer patients.

Keskin O, Aksoy S, Babacan T, Sarici F, Kertmen N, Solak M, Turkoz FP, Arik Z, Esin E, Petekkaya I, Altundag K. Keskin O, et al. Among authors: solak m. J BUON. 2013 Oct-Dec;18(4):824-30. J BUON. 2013. PMID: 24344004 Free article.

5

Association between common risk factors and molecular subtypes in breast cancer patients.

Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K. Turkoz FP, et al. Among authors: solak m. Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14. Breast. 2013. PMID: 22981738 Free article.

6

Association of breast cancer subtypes and body mass index.

Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K. Petekkaya I, et al. Among authors: solak m. Tumori. 2013 Mar-Apr;99(2):129-33. doi: 10.1177/030089161309900201. Tumori. 2013. PMID: 23748802

7

Molecular subtypes in patients with inflammatory breast cancer; a single center experience.

Kertmen N, Babacan T, Keskin O, Solak M, Sarici F, Akin S, Arik Z, Aslan A, Ates O, Aksoy S, Ozisik Y, Altundag K. Kertmen N, et al. Among authors: solak m. J BUON. 2015 Jan-Feb;20(1):35-9. J BUON. 2015. PMID: 25778293 Free article.

8

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.

Solak M, Turkoz FP, Keskin O, Aksoy S, Babacan T, Sarici F, Kertmen N, Sever AR, Altundag K. Solak M, et al. J BUON. 2015 May-Jun;20(3):737-45. J BUON. 2015. PMID: 26214625 Free article.

9

Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?

Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, Ozisik Y, Altundag K. Arslan C, et al. Among authors: solak m. Am Surg. 2012 Sep;78(9):992-9. Am Surg. 2012. PMID: 22964210

10

Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine.

Petekkaya I, Gezgen G, Roach EC, Solak M, Gullu I. Petekkaya I, et al. Among authors: solak m. J BUON. 2012 Oct-Dec;17(4):796. J BUON. 2012. PMID: 23335544 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters